StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3067% below fair value
$11.75−0.23 (-1.92%)

Close on Nov 20, 2026Market cap $131.40MP/E –Yield 0.00%

Medifast free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Medifast's free cash flow for the twelve months ending Sep 30, 2026 was -$3.87M, down 698.9% year over year. For fiscal 2025 it was $1.25M, down 92.7% from the year before. Over ten years it grew -26.3% a year on average. The highest annual figure on record is $177.89M in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.25M-92.7%
FY2024Dec 31, 2024$17.02M-87.9%
FY2023Dec 31, 2023$141.17M-20.6%
FY2022Dec 31, 2022$177.89M+194.8%
FY2021Dec 31, 2021$60.34M-56.7%
FY2020Dec 31, 2020$139.31M+87.7%
FY2019Dec 31, 2019$74.20M+32.8%
FY2018Dec 31, 2018$55.88M+39.7%
FY2017Dec 31, 2017$40.00M+78.0%
FY2016Dec 31, 2016$22.47M-15.5%
FY2015Dec 31, 2015$26.59M+43.6%
FY2014Dec 31, 2014$18.51M-40.2%
FY2013Dec 31, 2013$30.97M-3.6%
FY2012Dec 31, 2012$32.14M+56.0%
FY2011Dec 31, 2011$20.60M+23.2%
FY2010Dec 31, 2010$16.71M+19.1%
FY2009Dec 31, 2009$14.04M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.87M-73.3%
Q2 FY2026Jun 30, 2026$728.00K–
Q1 FY2026Mar 31, 2026-$836.00K-144.4%
Q4 FY2025Dec 31, 2025-$6.63M–
Q3 FY2025Sep 30, 2025$10.75M+39.9%
Q2 FY2025Jun 30, 2025-$4.76M-142.7%
Q1 FY2025Mar 31, 2025$1.88M-65.4%
Q4 FY2024Dec 31, 2024-$7.23M-175.5%
Q3 FY2024Sep 30, 2024$7.68M-72.8%
Q2 FY2024Jun 30, 2024$11.13M-73.1%
Q1 FY2024Mar 31, 2024$5.44M-91.2%
Q4 FY2023Dec 31, 2023$9.58M-77.6%
Q3 FY2023Sep 30, 2023$28.25M-47.3%
Q2 FY2023Jun 30, 2023$41.40M+1.2%
Q1 FY2023Mar 31, 2023$61.94M+52.3%
Q4 FY2022Dec 31, 2022$42.68M–
Q3 FY2022Sep 30, 2022$53.63M+891.1%
Q2 FY2022Jun 30, 2022$40.92M+208.1%
Q1 FY2022Mar 31, 2022$40.66M-33.0%
Q4 FY2021Dec 31, 2021-$19.08M-207.2%
Q3 FY2021Sep 30, 2021$5.41M-85.7%
Q2 FY2021Jun 30, 2021$13.28M-76.8%
Q1 FY2021Mar 31, 2021$60.73M+129.7%
Q4 FY2020Dec 31, 2020$17.79M-2.9%
Q3 FY2020Sep 30, 2020$37.85M+141.9%
Q2 FY2020Jun 30, 2020$57.23M+378.9%
Q1 FY2020Mar 31, 2020$26.44M-6.5%
Q4 FY2019Dec 31, 2019$18.32M+34.3%
Q3 FY2019Sep 30, 2019$15.65M+170.0%
Q2 FY2019Jun 30, 2019$11.95M-39.4%
Q1 FY2019Mar 31, 2019$28.29M+69.2%
Q4 FY2018Dec 31, 2018$13.64M+49.6%
Q3 FY2018Sep 30, 2018$5.80M-48.0%
Q2 FY2018Jun 30, 2018$19.72M+45.9%
Q1 FY2018Mar 31, 2018$16.72M+169.1%
Q4 FY2017Dec 31, 2017$9.12M–
Q3 FY2017Sep 30, 2017$11.15M–
Q2 FY2017Jun 30, 2017$13.52M–
Q1 FY2017Mar 31, 2017$6.21M–
Q4 FY2016Dec 31, 2016-$1.15M–

More Medifast figures

See a number that looks wrong?